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Summary Ochrobactrum anthropi is a non-fermenting Gram-negative rod that was identified
as a pathogenic microorganism during the past decade. O. anthropi is extensively distributed in
the environment, and has been found in hospital and environmental water sources. O. anthropi
infection is rare in childhood. We report a case of O. anthropi bacteremia in a preterm infant with
a peritoneal lavage catheter and meconium peritonitis.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Ochrobactrum anthropi is an aerobic, motile, oxidase-posi-
tive bacterium that belongs to the group of non-Enterobac-
teriaceae, non-fermentative aerobic Gram-negative
bacilli.1,2 O. anthropi is extensively distributed in the envir-
onment, and has been found in hospital and environmental
water sources. It has been isolated from different specimens
and might be part of the normal flora of the large intestine.
The organism is presently considered to be an opportunistic
pathogen. O. anthropi infection is rare in childhood and is
usually associated with immunocompromised patients with
indwelling catheters.1—3 To the best of our knowledge, there
is one report in the literature of O. anthropi meningitis in a
preterm infant.1 Here, we describe a case of O. anthropi
bacteremia in a preterm infant with a peritoneal lavage
catheter and meconium peritonitis.* Corresponding author. Trakya U¨niversitesi Tıp Faku¨ltesi, C¸ocuk
Sag˘lıg˘ı ve Hastalıkları Anabilim Dalı, 22030 Edirne, Tu¨rkiye.
Tel.: +90 284 235 76 41x4917; fax: +90 284 235 23 38.
E-mail address: ridvan_duran@yahoo.com (R. Duran).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.06.027Case report
A male preterm infant was born vaginally at 29 weeks of
gestation to a 35-year-old gravida 1 mother who developed
vaginal hemorrhage at 28 weeks of gestation. Apgar scores
were 5 at 1 minute and 7 at 5 minutes. His birth weight was
1090 g (10—50th percentile); height 37.5 cm (10—50th per-
centile) and head circumference 27 cm (10—50th percentile).
On admission to the Neonatal Unit, the infant was tachypneic
and had severe retractions, nasal flaring and grunting. Chest
radiography showed opaque lungs; therefore, one dose of
surfactant was administered, and ampicillin and amikacin
were commenced. Full blood count and biochemistry were
normal. While he was receiving mechanical ventilation sup-
port, a blue-purple discoloration developed on the skin of his
abdomen on day 2 postnatally. Pediatric surgeons carried out
paracentesis and meconium was obtained as paracentesis
material. Thus, he was diagnosed with necrotizing entero-
colitis (NEC) stage III B and received metronidazole therapy
additionally. Because of his clinical instability, a peritoneal
lavage catheter was inserted and peritoneal irrigation was
performed every four hours. O. anthropi was isolated fromPublished by Elsevier Ltd. All rights reserved.
Figure 1 Abdominal radiograph showing intestinal perforation.
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postnatal day 7 and culture from the peritoneal lavage cathe-
teronpostnatalday11.O.anthropiwas resistant toampicillin-
sulbactam, cefepime, ceftriaxone, tobramycin, amikacin,
aztreonam and trimethoprim-sulfamethoxazole, and was sus-
ceptible to ciprofloxacin, gentamicin and imipenem. There-
fore, his antibiotic regime was changed to ciprofloxacin and
gentamicin. On postnatal day 9, the blue-purple color of the
skin on his abdomen increased. Abdominal X-ray examination
revealed intestinal perforation (Figure 1). A new peritoneal
lavage catheter was inserted and peritoneal irrigation was
carried out. After one week of antimicrobial therapy, blood
culture results were reported as sterile, so antibiotic treat-
ment was continued for 14 days and then stopped. Following
extubation on postnatal day 18, he developed abdominal
distention and bilious vomiting. During surgery performed on
postnatal day 19, a perforation in the ileal region and meco-
niumparticles in theabdominal cavitywerenoted.A5 cmileac
segment was resected and a double-barrel ileostomy was
performed. However, while on postoperative mechanical ven-
tilation support, our patient died on postnatal day 26.
Discussion
We describe a case of O. anthropi bacteremia in a preterm
infant associated with a peritoneal lavage catheter, meco-
nium ileus and meconium peritonitis.
O. anthropi is a non-fermenting Gram-negative rod that
was identified as a pathogenic microorganism during the past
decade. Previously known as CDC group Vd, in 1988 it was
classified as an independent group. Its differentiation fromother Gram-negative rods is difficult.2 O. anthropi resembles
Pseudomonas aeruginosa, because it is water borne and
might cause nosocomial infection. In addition, both species
are Gram-negative, non-lactose-fermenting bacilli, and both
grow well on McConkey agar. O. anthropi differs from Pseu-
domonas species in that it lacks pigment production and has
peritrichous flagella.2
O. anthropi has been isolated from different specimens,
such as blood, urine, stool, throat and wounds, and might be
part of the normal flora of the large intestine. O. anthropi is
an opportunist of low pathogenicity and generally affects
immunocompromised patients with clinical devices. In more
than half of the cases described in children, the patients
were immunocompromised.1—3 The first case described in
pediatrics was a 14-year-old boy with osteochondritis in
1987.4 The most common clinical manifestation of O.
anthropi appears to be vascular catheter-related bactere-
mia; the first case of catheter-related bacteremia was
reported in 1992 by Cieslak et al.5 Pyogenic infections have
been related to foreign bodies, including meningitis and bone
flap osteomyelitis after the implantation of contaminated
allograft tissue, and endophthalmitis after vitreous sur-
gery.5—7 Other reported infections include bacteremia in
pediatric oncology patients and community-acquired infec-
tions in immunocompromised patients.3,8 Infections in nor-
mal hosts have been reported, including intravenous
catheter infection, endocarditis and osteomyelitis.9,10 To
date, there is only one report of a preterm infant with O.
anthropi meningitis.1 Our case, however, concerned a pre-
term infant with O. anthropi bacteremia in association with a
peritoneal lavage catheter and meconium peritonitis.
There is no consensus about the best treatment for O.
anthropi bacteremia. Monotherapy with an aminoglycoside
or appropriate antibiotic has yielded good clinical
response.3,8 Strains of O. anthropi are susceptible to tri-
methoprim-sulfamethoxazole, tetracycline, aminoglycosides
and fluoroquinolones. Resistance to b-lactam antibiotics is
common, although isolates susceptible to ceftriaxone, cefo-
taxime, cefoperazone and imipenem have occasionally been
reported.3,8 However, treatment failure with imipenem has
been reported, despite the in vitro susceptibility of the
strains.11 Therefore, our patient was treated with ciproflox-
acin and gentamicin in accordance with the antibiogram.
In conclusion, we present the first case of O. anthropi
bacteremia occurring in a preterm infant with a peritoneal
lavage catheter, who had undergone intestinal surgery and
suffered meconium peritonitis.
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